Biometrics

• 

  Publication Venue For

  • Group sequential testing for cluster randomized trials with time-to-event endpoint..  78:1353-1364. 2022
  • Microbiome subcommunity learning with logistic-tree normal latent Dirichlet allocation. 2022
  • Generalized linear models with linear constraints for microbiome compositional data.  75:235-244. 2019
  • Convex mixture regression for quantitative risk assessment..  74:1331-1340. 2018
  • A model for paired‐multinomial data and its application to analysis of data on a taxonomic tree.  73:1266-1278. 2017
  • Bayesian genome- and epigenome-wide association studies with gene level dependence..  73:1018-1028. 2017
  • Nonparametric Bayes modeling for case control studies with many predictors..  72:184-192. 2016
  • Multilevel quantile function modeling with application to birth outcomes..  71:508-519. 2015
  • Report of the editors-2014.  71:fmvii-fmix. 2015
  • Report of the Editors-2013.  70:vii-ix. 2014
  • Bayesian latent factor regression for functional and longitudinal data..  68:1064-1073. 2012
  • Spatial-temporal modeling of the association between air pollution exposure and preterm birth: identifying critical windows of exposure..  68:1157-1167. 2012
  • Space-time data fusion under error in computer model output: an application to modeling air quality..  68:837-848. 2012
  • The k-ZIG: flexible modeling for zero-inflated counts..  68:878-885. 2012
  • Modeling adverse birth outcomes via confirmatory factor quantile regression..  68:92-100. 2012
  • Detecting disease outbreaks using local spatiotemporal methods..  67:1508-1517. 2011
  • Bayesian variable selection for latent class models..  67:917-925. 2011
  • Semiparametric bayes' proportional odds models for current status data with underreporting..  67:1111-1118. 2011
  • High-dimensional variable selection in meta-analysis for censored data..  67:504-512. 2011
  • Report of the Editors-2010.  67:7-9. 2011
  • Bayesian variable selection for multivariate spatially varying coefficient regression..  66:772-782. 2010
  • Dynamic model for multivariate markers of fecundability..  66:905-913. 2010
  • Bayesian semiparametric multiple shrinkage..  66:455-462. 2010
  • Report of the editors - 2009.  66:7-9. 2010
  • A Bayesian latent variable mixture model for longitudinal fetal growth..  65:1233-1242. 2009
  • Bayesian hierarchical functional data analysis via contaminated informative priors..  65:772-780. 2009
  • Testing random effects in the linear mixed model using approximate bayes factors..  65:369-376. 2009
  • Report of the Editors - 2008.  65. 2009
  • Nonparametric bayes testing of changes in a response distribution with an ordinal predictor..  64:413-423. 2008
  • Nonparametric inference on median residual life function..  64:157-163. 2008
  • Report of the editors - 2007.  64. 2008
  • A copula approach for detecting prognostic genes associated with survival outcome in microarray studies..  63:1089-1098. 2007
  • Bayesian adaptive regression splines for hierarchical data..  63:724-732. 2007
  • Bayesian modeling of multiple episode occurrence and severity with a terminating event..  63:381-388. 2007
  • Cox regression methods for two-stage randomization designs..  63:422-428. 2007
  • A semiparametric empirical likelihood method for biased sampling schemes with auxiliary covariates..  62:1149-1160. 2006
  • Bayesian semiparametric dynamic frailty models for multiple event time data..  62:1044-1052. 2006
  • A general approach for two-stage analysis of multilevel clustered non-Gaussian data..  62:752-759. 2006
  • Smoothing spline-based score tests for proportional hazards models..  62:803-812. 2006
  • Bayesian covariance selection in generalized linear mixed models..  62:446-457. 2006
  • Polydesigns and causal inference..  62:343-351. 2006
  • The authors replied as follows [2].  62:623-624. 2006
  • Bayesian inferences on umbrella orderings..  61:1018-1026. 2005
  • Discussion on "statistical issues arising in the Women's Health Initiative".  61:933-935. 2005
  • The evaluation of treatment when center-specific selection criteria vary with respect to patient risk..  61:942-949. 2005
  • Comments about Joint Modeling of Cluster Size and Binary and Continuous Subunit-Specific Outcomes..  61:862-866. 2005
  • Bayesian inferences on predictors of conception probabilities..  61:126-133. 2005
  • Modeling the effects of a bidirectional latent predictor from multivariate questionnaire data..  60:926-935. 2004
  • Bayesian modeling of multiple lesion onset and growth from interval-censored data..  60:676-683. 2004
  • Bayesian multivariate logistic regression..  60:739-746. 2004
  • Bayesian isotonic regression and trend analysis..  60:398-406. 2004
  • Cutpoint selection for categorizing a continuous predictor..  60:504-509. 2004
  • Selecting factors predictive of heterogeneity in multivariate event time data..  60:352-358. 2004
  • Conditional estimation for generalized linear models when covariates are subject-specific parameters in a mixed model for longitudinal measurements..  60:1-7. 2004
  • A bivariate frailty model with a cure fraction for modeling familial correlations in diseases..  59:1178-1183. 2003
  • Bayesian inferences in the Cox model for order-restricted hypotheses..  59:916-923. 2003
  • Random effects selection in linear mixed models..  59:762-769. 2003
  • Semiparametric estimation of treatment effect in a pretest-posttest study..  59:1046-1055. 2003
  • A Bayesian approach for joint modeling of cluster size and subunit-specific outcomes..  59:521-530. 2003
  • Bayesian inference on order-constrained parameters in generalized linear models..  59:286-295. 2003
  • Bayesian latent variable models for median regression on multiple outcomes..  59:296-304. 2003
  • Accounting for nonignorable verification bias in assessment of diagnostic tests..  59:163-171. 2003
  • Bayesian modeling of time-varying and waning exposure effects..  59:83-91. 2003
  • A semiparametric likelihood approach to joint modeling of longitudinal and time-to-event data..  58:742-753. 2002
  • Bayesian modeling of incidence and progression of disease from cross-sectional data..  58:813-822. 2002
  • Overall concordance correlation coefficient for evaluating agreement among multiple observers..  58:1020-1027. 2002
  • Weighted least-squares approach for comparing correlated kappa..  58:1012-1019. 2002
  • A nonparametric Bayesian modeling approach for cytogenetic dosimetry..  58:593-600. 2002
  • A proportional hazards model for incidence and induced remission of disease..  58:71-78. 2002
  • Bayesian models for multivariate current status data with informative censoring..  58:79-88. 2002
  • Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials..  58:48-57. 2002
  • Frailty models with missing covariates..  58:98-109. 2002
  • Bayesian modeling of the level and duration of fertility in the menstrual cycle..  57:1067-1073. 2001
  • Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data..  57:1207-1218. 2001
  • Linear mixed models with flexible distributions of random effects for longitudinal data..  57:795-802. 2001
  • Modeling concordance correlation via GEE to evaluate reproducibility..  57:931-940. 2001
  • A flexible parametric model for combining current status and age at first diagnosis data..  57:396-403. 2001
  • Factor analytic models of clustered multivariate data with informative censoring..  57:302-308. 2001
  • Robust two-stage estimation in hierarchical nonlinear models..  57:266-272. 2001
  • A diagnostic for Cox regression with discrete failure-time models..  56:996-1001. 2000
  • Distinguishing effects on tumor multiplicity and growth rate in chemoprevention experiments..  56:1068-1075. 2000
  • Correcting for measurement error in individual-level covariates in nonlinear mixed effects models..  56:368-375. 2000
  • Estimating data transformations in nonlinear mixed effects models..  56:65-72. 2000
  • Modeling human fertility in the presence of measurement error..  56:288-292. 2000
  • Bayesian inference for prevalence in longitudinal two-phase studies..  55:1145-1150. 1999
  • A Bayesian hierarchical approach for combining case-control and prospective studies..  55:858-866. 1999
  • Assessing distributions of estimated drug shelf lives in stability analysis..  55:896-899. 1999
  • Modeling tumor onset and multiplicity using transition models with latent variables..  55:965-970. 1999
  • Summarizing the motion of self-propelled cells: applications to sperm motility..  55:537-543. 1999
  • Estimating the parameters in the Cox model when covariate variables are measured with error..  54:1407-1419. 1998
  • Genetic linkage analysis of complex genetic traits by using affected sibling pairs..  54:1238-1246. 1998
  • Approaches for optimal sequential decision analysis in clinical trials..  54:964-975. 1998
  • Dose-dependent number of implants and implications in developmental toxicity..  54:558-569. 1998
  • Goodness-of-fit tests for GEE modeling with binary responses..  54:720-729. 1998
  • The effect of serial dilution error on calibration inference in immunoassay..  54:19-32. 1998
  • Calibration inference based on multiple runs of an immunoassay..  53:1304-1317. 1997
  • A generalized estimating equation approach for modeling random length binary vector data..  53:1116-1124. 1997
  • Practical Bayesian inference using mixtures of mixtures..  52:1334-1341. 1996
  • The effect of variance function estimation on nonlinear calibration inference in immunoassay data..  52:158-175. 1996
  • Bayesian analysis of proportional hazards models built from monotone functions..  51:843-852. 1995
  • Multiple population models for multivariate random length data--with applications in clinical trials..  51:195-204. 1995
  • Statistical inference in stability analysis.  50:753-763. 1994
  • Population pharmacokinetic/pharmacodynamic methodology and applications: a bibliography..  50:566-575. 1994
  • Some Simple Methods for Estimating Intraindividual Variability in Nonlinear Mixed Effects Models.  49:59-59. 1993
  • Estimating drug shelf-life with random batches..  47:1071-1079. 1991
  • Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach..  44:837-845. 1988
  • Characterizing activity-dependent processes with a piecewise exponential model..  44:549-559. 1988
  • Analysis of the volume of red blood cells: application of the expectation-maximization algorithm to grouped data from the doubly-truncated lognormal distribution..  42:143-158. 1986
  • Sensitivity and specificity of a monitoring test..  41:947-958. 1985
  • IMPROVING ESTIMATES OF PREVALENCE BY MULTIPLE OBSERVATION.  41:321-321. 1985
  • A comparison of test statistics for assessing the effects of concomitant variables in survival analysis..  39:341-350. 1983
  • A variance components approach to categorical data models with heterogeneous cell populations: analysis of spatial gradients in lung cancer mortality rates in North Carolina counties..  37:259-269. 1981
  • Multiple Probit Analysis with a Nonzero Background.  36:659-659. 1980
  • On the complexity of investigating chronic illness..  36:333-335. 1980
  • Longitudinal analysis of the dynamics and risk of coronary heart disease in the Framingham Study..  35:575-585. 1979
  • APPLICATIONS OF THE MIP TO ENVIRONMENTAL DATA.  35:888-888. 1979
  • A linear models application of competing risks to multiple causes of death..  34:581-591. 1978
  • Compartment model approach to the estimation of tumor incidence and growth: investigation of a model of cancer latency..  34:377-389. 1978
  • An extension of the sign test for replicated measurements..  33:453-461. 1977
  • The Biometric Society, the first twenty-five years (1947-1972)..  28:285-311. 1972
  • Analysis of categorical data by linear models..  25:489-504. 1969
  • Discussion on experimental design; a survey of types of experimental designs..  6:317-318. 1950
  • DISTRIBUTION OF THE NUMBER OF ZERO CROSSINGS OF A GAUSSIAN STOCHASTIC-PROCESS - A SIMULATION STUDY 1981